ADVIA CENTAUR XP HCV ASSAY
Report
- Report Number
- 1219913-2012-00411
- Event Type
- Malfunction
- Date Received
- December 19, 2012
- Date of Event
- November 19, 2012
- Report Date
- November 19, 2012
- Manufacturer
- SIEMENS HEALTHCARE DIAGNOSTICS, INC.
- Product Code
- MZO
- PMA / PMN Number
- P030056
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- RS
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
THE CAUSE FOR THE DISCORDANT (B)(6) RESULTS WHEN COMPARED TO THE ALTERNATE METHOD IS UNKNOWN. NO FURTHER EVALUATION OF THE DEVICE IS REQUIRED. THE IFU (113843 REV. R) THAT IS DISTRIBUTED OUTSIDE THE US STATES IN THE LIMITATIONS SECTION: "A NEGATIVE TEST RESULT DOES NOT EXCLUDE THE POSSIBILITY OF EXPOSURE TO OR INFECTION WITH (B)(6). (B)(6) ANTIBODIES MAY BE UNDETECTABLE IN SOME STAGES OF THE INFECTION AND IN SOME CLINICAL CONDITIONS." "ASSAY PERFORMANCE CHARACTERISTICS HAVE NOT BEEN ESTABLISHED WHEN THE ADVIA CENTAUR HCV ASSAY IS USED IN CONJUNCTION WITH OTHER MANUFACTURERS' ASSAYS FOR SPECIFIC (B)(6)."
NEGATIVE ADVIA CENTAUR XP HCV RESULTS WERE OBTAINED ON A PATIENT SAMPLE. THE PATIENT SAMPLE WAS TESTED ON AN ALTERNATE METHOD AND THE RESULTS WERE (B)(6). SIMILAR RESULTS WERE OBTAINED FOR A SECOND PATIENT. IT IS UNKNOWN IF PATIENT TREATMENT WAS ALTERED OR PRESCRIBED. THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCORDANT ADVIA CENTAUR XP HCV RESULT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ADVIA CENTAUR XP HCV ASSAY | HEPATITIS C VIRUS (ANTI-HCV) ASSAY | MZO | SIEMENS HEALTHCARE DIAGNOSTICS, INC. | N/A | UNKNOWN |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |